Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665588 | SCV000789735 | uncertain significance | Glucose-6-phosphate transport defect | 2017-02-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665588 | SCV003275571 | uncertain significance | Glucose-6-phosphate transport defect | 2022-08-21 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the SLC37A4 gene. It does not directly change the encoded amino acid sequence of the SLC37A4 protein. It affects a nucleotide within the consensus splice site. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 550756). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003155265 | SCV003844545 | uncertain significance | not specified | 2023-02-11 | criteria provided, single submitter | clinical testing |